EXHIBIT 99.1


       Greatbatch and BIOMEC Enter Into a Definitive Agreement


    CLARENCE, N.Y.--(BUSINESS WIRE)--March 19, 2007--Greatbatch, Inc.
(NYSE: GB) and BIOMEC, Inc. today announced that they have entered
into a definitive agreement whereby Greatbatch will acquire
substantially all of the assets of BIOMEC, Inc. for $11.4 million in
cash and future additional considerations. This agreement is subject
to BIOMEC shareholder approval.

    BIOMEC Inc. was established in 1998 with the objective of
accelerating promising technology from major medical and academic
institutions, national laboratories, and internal proprietary
developments to successful commercial products. BIOMEC operates in
Cleveland, OH and has built a highly effective engineering team with
diverse capabilities in medical device development that provides
creative solutions for customer's product development needs. In
collaboration with Dr. Roger Marchant, President of Nanomimetics Inc.
and Associate Professor of Biomedical Engineering and Director, Center
for Cardiovascular Biomaterials at Case Western Reserve University,
BIOMEC is developing a novel-polymer coating (biomimetic) that mimics
the surface of endothelial cells of blood vessels with potential use
on several medical devices, including in-dwelling central venous
catheters, cardiac pacing leads, and extra-corporeal blood pump
circuits in bypass surgery. Additionally, BIOMEC has a product
development and an investment partnership in IntElect Medical, an
early stage neurostimulation device company that works in conjunction
with the Cleveland Clinic.

    The acquisition will expand Greatbatch's ability to provide device
design and engineering services to its customers. It will also
accelerate internal efforts to integrate Greatbatch's components into
more complex device subsystems for its customers.

    Mauricio Arellano, Senior Vice President - Medical Solutions, for
Greatbatch stated, "We are very excited about this transaction. It is
a unique opportunity to advance our strategic intent to offer more
complete device design and engineering service capabilities. In
addition, BIOMEC is working on a number of proprietary technologies
and maintains strategic partnerships with several key early stage
device companies. We're specifically excited about a biomimetic
coating under development and expanding the strategic partnership it
has with IntElect Medical."

    About Greatbatch, Inc.

    Greatbatch, Inc. is a leading developer and manufacturer of
critical components used in implantable medical devices and other
technically demanding applications. Additional information about the
company is available at www.greatbatch.com.


    CONTACT: Investors:
             Greatbatch, Inc.
             Anthony W. Borowicz, 716-759-5809
             Treasurer and Director, Investor Relations
             tborowicz@greatbatch.com